Allergy Treatment Market

Allergies are body's reaction to a normally harmless substance such as pollen, molds, animal dander, latex, certain foods, and insect stings. Allergy occurs when person reacts to substances in the environment that are harmless to most people. The treatment for an allergy depends on what people are allergic to. Medications, such as antihistamines and decongestants, used as a short-term treatment for allergies. Red and itchy skin can sometimes be treated with over-the-counter creams and lotions. Allergy immunotherapy could be the option for people with severe and persistent allergies who are unable to control their symptoms using the measures above.

Market Dynamics:

Increasing incidence of allergic disease or allergies, increasing demand for allergy treatment, continuous development of novel therapies to treat allergies, and increasing awareness among people are some major factors expected to boost growth of the global allergy treatment market. Globally, the prevalence of allergic diseases is rising rapidly in both developing and developed countries. Moreover, complexity and severity continue to increase especially in both children and young adults. According to the World Health Organization (WHO), around 30-40% of the world’s population is currently affected by one or more allergic conditions.

Therefore, there is an increasing demand for safe and effective treatment. In January 2021, the European Commission (EC) approved Palforzia for the treatment of peanut allergy, making it the first treatment for the condition. Produced by Aimmune Therapeutics, Palforzia is indicated in patients aged four to 17 years with a confirmed diagnosis of peanut allergy.

Key features of the study:

• This report provides in-depth analysis of the global allergy treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global allergy treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Stallergenes Greer PLC, Sanofi SA, Novartis International AG, Dermapharm Holding SE, Leti Pharma, Johnson & Johnson, GlaxoSmithKline PLC, Nicox SA, F. Hoffmann-La Roche Ltd., Allergy Therapeutics, AbbVie (Allergan), Bausch Health Companies Inc., Teva Pharmaceutical Industries, ALK-Abello AS, and Alembic Pharmaceuticals Limited, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global allergy treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy treatment market.

Detailed Segmentation:

• Global Allergy Treatment Market, By Type:
• • Eye Allergy
  • Rhinitis
  • Asthma
  • Skin Allergy
  • Food Allergies
  • Other Allergies
• Global Allergy Treatment Market, By Treatment:
• • Anti-allergy Drugs
  • Immunotherapy
• Global Allergy Treatment Market, By Geography:
• • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America